GILD vs INNV · P/E 18, rev $7.80B vs rev $853.7M
Gilead Sciences Inc (GILD) versus InnovAge Holding Corp (INNV) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
InnovAge Holding Corp (INNV) is a medical care facilities company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported INNV revenue for 2025-06-30 was $853.7M. Net income was -$35.3M. INNV currently screens at market cap $990.9M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. INNV currently screens at market cap $990.9M.
Not investment advice. Open the GILD and INNV stock pages for the full models.
Not investment advice.